Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine versus sufentanil for postoperative IV-PCA after major laparoscopic abdominal surgery
ChiCTR2600131041Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tegileridine and sufentanil in postoperative pain (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Proportion of patients achieving SAME within 48 hours postoperatively. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
tegileridinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600131041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131041.